IndiaOne Finance - Company Dashboard

Governance Classic Home

Zim Laboratories LtdPharmaceuticalsINE518E01015Consolidated₹135.30-2.45 (-1.78%)Jun-26

Valuation

Market Cap₹725.64 Cr

TTM PE165.26x

Forward PE111.68x

PEG-5.32

Book Value₹55.30

P/B2.45x

TTM EPS₹0.82

Fwd EPS₹1.21

TTM Revenue₹396.82 Cr

TTM PAT₹3.69 Cr

TTM EBITDA₹28.20 Cr

TTM EBIT₹7.72 Cr

Last Qtr PAT₹-4.02 Cr

Last Qtr EBITDA₹2.45 Cr

Last Qtr EBIT₹-2.92 Cr

Profitability

ROE1.25%

ROCE4.49%

TTM NPM0.93%

TTM EBITDA %7.11%

Curr OPM-4.22%

Last OPM3.36%

Curr NPM—

Last NPM—

Curr EPS₹-0.75

Last EPS₹0.76

Balance sheet

Equity₹53.50 Cr

Reserve₹242.65 Cr

Total Debt₹125.73 Cr

D/E0.42x

Interest %-90.55%

Curr Interest₹3.64 Cr

Price / range

Close₹135.51

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-1.75%

1W-2.63%

1M+18.42%

3M+18.68%

6M+100.33%

1Y+78.84%

2Y+19.97%

3Y+11.67%

5Y+488.66%

Diwali+92.21%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	93.05+30.3%	102.85	107.81	88.39	71.43	370.48
Other Income	0.99	6.16	1.71	2.04	1.48	11.39
Total Income	94.03+29.0%	109.01	109.52	90.44	72.90	381.87
Interest	3.64	3.31	3.43	3.16	3.30	13.20
Expenditure	-99.46-32.3%	-104.49	-103.59	-90.21	-75.19	-373.47
PBDT	0	0	0	0	0	0
EBITDA	2.40-44.6%	6.57	12.50	6.17	4.33	29.58
Depreciation	-5.17	-4.90	-4.85	-4.83	-4.79	-19.37
EBIT	-2.77-502.2%	1.67	7.65	1.34	-0.46	10.21
PBT	-5.42-137.7%	4.53	5.93	0.23	-2.28	8.40
Tax	1.55	-1.24	-1.67	-0.11	0.59	-2.44
Equity	53.55	53.50	0	0	48.73	53.50
OPM	-5.76	4.16	5.50	0.26	-3.13	2.20
Net Profit	-3.88-129.6%	3.28	4.26	0.12	-1.69	5.97
NPM	-4.13	3.01	3.95	0.13	-2.32	1.56
EPS	-0.72-105.7%	0.67	0.87	0.03	-0.35	1.22

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	370.48-1.4%	375.64+2.8%	365.47-7.8%	396.53+20.3%	329.49+8.5%	303.63
Other Income	11.39	5.62	4.69	6.43	4.51	2.45
Total Income	381.87+0.2%	381.26+3.0%	370.16-8.1%	402.96+20.6%	334+9.1%	306.08
Expenditure	-373.47-2.7%	-363.64-4.8%	-347.13+5.4%	-367.04-16.6%	-314.70-7.7%	-292.32
Interest	-13.20	-11.39	-6.92	-5.58	-8.31	-10.89
PBDT	0	0	0	0	0	0
EBITDA	29.58-31.7%	43.28+8.0%	40.09-21.7%	51.20+34.9%	37.94+3.1%	36.81
Depreciation	-19.37	-19.89	-14.83	-16.13	-14.84	-14.61
EBIT	10.21-56.3%	23.39-7.4%	25.26-28.0%	35.07+51.8%	23.10+4.1%	22.20
PBT	8.40-52.3%	17.61-23.6%	23.04-35.9%	35.92+86.1%	19.30+124.9%	8.58
Tax	-2.44	-5.87	-6.28	-10.91	-6.28	-2.96
Equity	53.50	48.73	0	0	0	0
OPM (%)	2.20	4.62	6.00	9.00	6.00	3.00
Net Profit	5.97-49.1%	11.74-30.0%	16.76-33.0%	25.01+92.2%	13.01+131.5%	5.62
NPM (%)	1.56	3.08	5.00	6.00	4.00	2.00
EPS (Rs)	1.22-49.4%	2.41-29.9%	3.44-32.9%	5.13-36.0%	8.01+131.5%	3.46
CEPS	1.22	2.41	3.44	5.13	8.01	3.46

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	94.18+31.2%	105.27	108.66	88.71	71.76	374.40
Other Income	0.99	6.16	1.70	2.04	1.48	11.38
Total Income	95.17+30.0%	111.44	110.36	90.75	73.23	385.78
Interest	3.64	3.31	3.43	3.16	3.30	13.20
Expenditure	-100.74-33.1%	-106.49	-104.31	-91.10	-75.66	-377.57
PBDT	0	0	0	0	0	0
EBITDA	2.45-42.5%	7.19	12.81	5.75	4.26	30.01
Depreciation	-5.37	-5.10	-5.03	-4.98	-4.86	-19.98
EBIT	-2.92-386.7%	2.09	7.78	0.77	-0.60	10.03
PBT	-5.57-129.2%	4.94	6.05	0	-2.43	8.21
Tax	1.56	-1.20	-1.65	-0.08	0.56	-2.37
Equity	53.55	53.50	0	0	48.73	53.50
OPM	-5.85	4.43	5.48	0.00	-3.32	2.13
Net Profit	-4.02-115.0%	3.74	4.40	-0.43	-1.87	5.84
NPM	-4.22	3.36	3.99	-0.47	-2.55	1.51
EPS	-0.75-97.4%	0.76	0.90	-0.09	-0.38	1.19

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	374.40-1.2%	379.03+3.2%	367.42-7.8%	398.53+19.5%	333.43+8.5%	307.26
Other Income	11.38	5.78	5.18	6.41	4.40	2.34
Total Income	385.78+0.2%	384.82+3.3%	372.61-8.0%	404.94+19.9%	337.83+9.1%	309.60
Expenditure	-377.57-2.9%	-366.81-5.1%	-348.97+5.6%	-369.59-16.7%	-316.79-7.7%	-294.19
Interest	-13.20	-11.39	-6.92	-5.58	-8.31	-10.90
PBDT	0	0	0	0	0	0
EBITDA	30.01-31.4%	43.72+5.8%	41.32-20.5%	51.99+26.9%	40.98+3.1%	39.76
Depreciation	-19.98	-20.11	-15.95	-17.47	-16.03	-15.79
EBIT	10.03-57.5%	23.61-6.9%	25.37-26.5%	34.52+38.4%	24.95+4.1%	23.97
PBT	8.21-54.4%	18.01-23.8%	23.64-33.1%	35.36+68.1%	21.04+105.7%	10.23
Tax	-2.37	-5.84	-6.40	-10.92	-6.49	-2.91
Equity	53.50	48.73	0	0	0	0
OPM (%)	2.13	4.68	6.35	8.73	6.23	3.30
Net Profit	5.84-52.0%	12.17-29.4%	17.25-29.4%	24.44+68.0%	14.55+98.8%	7.32
NPM (%)	1.51	3.16	4.63	6.03	4.31	2.36
EPS (Rs)	1.19-52.4%	2.50-29.4%	3.54-29.3%	5.01-44.1%	8.96+99.1%	4.50
CEPS	1.19	2.50	3.54	5.01	8.96	4.50

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2019	Final Dividend	0.5	19 Sep 2019
2018	Final Dividend	1	03 Sep 2018

Bonus

Year	Ratio	Ex-Date
2022	2:1	22 Dec 2022
2018	1:1	04 Oct 2018

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split